Inventor · disambiguated record
Kazuhito Ueyama
Also filed as: UEYAMA KAZUHITO
3 granted patents·8 pending applications·16 citations·filing 2007–2022
68Inventor score
Top patents by PatentIndex Score
11 records- 0176US8283465B2Triazolopyridine compound, and action thereof as prolyl hydroxylase inhibitor or erythropoietin production-inducing agentMITANI IKUO·Filed 2010·Granted Oct 9, 2012·7 cites·30 claims
- 0276US2023348438A1Pyrazole compound and pharmaceutical use thereofJAPAN TOBACCO INC·Filed 2022·Application pending·0 cites
- 0375US8017612B2Piperazine compound and use thereof as a HCV polymerase inhibitorJAPAN TOBACCO INC·Filed 2007·Granted Sep 13, 2011·4 cites·40 claims
- 0474US8846746B2Pyrazole compound and pharmaceutical use thereofMIURA TOMOYA·Filed 2012·Granted Sep 30, 2014·5 cites·38 claims
- 0567US2020317644A1Pyrazole compound and pharmaceutical use thereofJAPAN TOBACCO INC·Filed 2019·Application pending·0 cites
- 0658US2015183763A1Pyrazole compound and pharmaceutical use thereofJAPAN TOBACCO INC·Filed 2014·Application pending·0 cites
- 0757US2018346449A1Pyrazole compound and pharmaceutical use thereofJAPAN TOBACCO INC·Filed 2017·Application pending·0 cites
- 0845US2013096155A1Triazolopyridine compound, and action thereof as prolyl hydroxylase inhibitor or erythropoietin production-inducing agentMITANI IKUO·Filed 2012·Application pending·0 cites
- 0943US2016145254A1Triazolopyridine compound, and action thereof as prolyl hydroxylase inhibitor or erythropoietin production-inducing agentJAPAN TOBACCO INC·Filed 2015·Application pending·0 cites
- 1042US2020017492A1Triazolopyridine compound, and action thereof as prolyl hydroxylase inhibitor or erythropoietin production-inducing agentJAPAN TOBACCO INC·Filed 2019·Application pending·0 cites
- 1140US2012107273A1New piperazine compound and use thereof as a hcv polymerase inhibitorABE HIROYUKI·Filed 2011·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Kazuhito Ueyama files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →